SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001070081-22-000009
Filing Date
2022-02-22
Accepted
2022-02-22 16:05:59
Documents
14
Period of Report
2022-02-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ptct-20220222x8k.htm   iXBRL 8-K 44288
2 EX-99.1 ptct-20220222ex991915bd3.htm EX-99.1 197241
3 GRAPHIC ptct-20220222ex991915bd3001.jpg GRAPHIC 7374
  Complete submission text file 0001070081-22-000009.txt   387682

Data Files

Seq Description Document Type Size
4 EX-101.SCH ptct-20220222.xsd EX-101.SCH 3043
5 EX-101.LAB ptct-20220222_lab.xml EX-101.LAB 15272
6 EX-101.PRE ptct-20220222_pre.xml EX-101.PRE 9664
8 EXTRACTED XBRL INSTANCE DOCUMENT ptct-20220222x8k_htm.xml XML 4676
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 22658053
SIC: 2834 Pharmaceutical Preparations